Abstract| Volume 18, ISSUE 6, SUPPLEMENT , S111, June 2016

A Descriptive Study on The Safety and Efficacy of Mesenchymal Stem Cell Therapy For Parkinson's Disease: A Case Series

      Objective: To describe the incidence and severity of infusion-related adverse events of mesenchymal stem cells (MSC) for Parkinson's disease, and report the efficacy in terms of clinical improvement in patients who underwent treatment.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect